Table 1.

Number of animals from each treatment group used in each set of analyses

Measurements	Control (n = 12)	Rosiglitazone (n = 9)
Cardiomyocyte measures	7 males = 4, females = 3	5 males = 3, females = 2
mRNA expression	5 males = 5, females = 0	7 males = 5, females = 2
Protein abundance	5 males = 5, females = 0	7 males = 5, females = 2
Contractility (Ca2+-activated force)	7 males = 3, females = 4	7 males = 5, females = 2
Contractility (Ca2+ sensitivity)	10 males = 6, females = 4	7 males = 4, females = 3